Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Wing’s drone delivery is coming to 150 more Walmarts

January 11, 2026

Supportive Living Services Expert Melissa Fields Shares Why Community Can Be Just as Important as Care for HelloNation

January 11, 2026

Kevlar in the classroom: teacher union warns of violence rise in Manitoba

January 11, 2026

Google’s AI Inbox could be a glimpse of Gmail’s future

January 11, 2026

The full history of TiVo, and how it changed TV forever

January 11, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » United States Clinical Trial Data Management Service Market Insights Report 2023-2028 Featuring Prominent Vendors – IQVIA,SYNEOS, ICON and Labcorp
Press Release

United States Clinical Trial Data Management Service Market Insights Report 2023-2028 Featuring Prominent Vendors – IQVIA,SYNEOS, ICON and Labcorp

By News RoomNovember 21, 20233 Mins Read
United States Clinical Trial Data Management Service Market Insights Report 2023-2028 Featuring Prominent Vendors – IQVIA,SYNEOS, ICON and Labcorp
Share
Facebook Twitter LinkedIn Pinterest Email
United States Clinical Trial Data Management Service Market Insights Report 2023-2028 Featuring Prominent Vendors – IQVIA,SYNEOS, ICON and Labcorp

Dublin, Nov. 21, 2023 (GLOBE NEWSWIRE) — The “US Clinical Trial Data Management Service Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering.

The US clinical trial data management system market is projected to reach a value of $1.29 billion by 2028 from $820 Million in 2022, growing at a CAGR of 7.8%

There are over 8000 clinical trials ongoing in the US. The duration for phase 3 clinical trials has doubled in the last decade, from 2 years in 2010 to 3.5 in 2021.

The data generated is huge, which is increasing the demand for clinical trial data management. The constant change in the regulatory pathways demands better data management skills and technology. The clinical data management service providers have expertise in this and keep track of every new rule change in the market.

Clinical trial data management involves the collection, handling, data cleaning, transfer, and traceability of clinical data. This process is outsourced to other companies for economic reasons, skilled labor, and time constraints. Smaller and mid-sized companies are outsourcing clinical trial data management to service providers in the market. This helps the companies to manage the data and launch it in the market in less time.

KEY HIGHLIGHTS:

  • Lack of in-house experience, expanding new drug pipelines, increasing complexity in clinical trials, and duration of clinical trials are forcing the companies to choose clinical data management service providers.
  • Phase 1 clinical trials take several months to a year to complete. Clinical trial outsourcing services are vital in minimizing time and cost. Collecting data from the clinical trials will also help in future studies. 70% of drugs move from phase 1 to the next phase, as stated by the US FDA
  • Small pharmaceutical start-ups are highly focused on drug discovery. The lack of development infrastructure and capital has compelled small biopharmaceutical companies to rely on clinical trial outsourcing services, including data management services.
  • Majority of the middle-sized companies are running their trials. When the working scale is beyond their ability to run effectively, but they want to remain involved, they choose the functional service provider model to augment their internal team. This is one of the unique ways to control the data with security. This is increasing the demand for the functional service provider model.
  • Small biotech and pharma companies accounted for 40% of contributions for new drug approval by the FDA. It shows the high market opportunities for clinical trial outsourcing market players, including data management service providers.
  • In 2019, more than 3000 contract research organizations were operating worldwide, of which more than 80% of medical device clinical trials happened in high-income countries, including the US. This number is constantly increasing. This is increasing the demand for US Clinical trial data management.

Key Attributes:

Report Attribute Details
No. of Pages 70
Forecast Period 2022 – 2028
Estimated Market Value (USD) in 2022 $0.82 Billion
Forecasted Market Value (USD) by 2028 $1.29 Billion
Compound Annual Growth Rate 7.8%
Regions Covered United States

VENDORS LIST

Key Vendors

Other Prominent Vendors

  • Thermo Fisher Scientific (PPD)
  • WuXi AppTec
  • Paraxel
  • Advanced Clinical
  • ProtaGene
  • Curial Global
  • AixialGroup
  • Cromos Pharma
  • Advanced Clinical
  • Criterium
  • KCR S.A
  • Medpace
  • Medelis
  • Worldwide Clinical Trials
  • Sofpromed
  • Veristat

SEGMENTATION & FORECAST

Phases

Type

  • Full Service
  • Functional Service
  • Standalone

End-User

  • Biotech & Pharmaceutical Companies
  • Medical Service Companies
  • Others

MARKET STRUCTURE

  • Market Dynamics
  • Competitive Landscape
  • Key Vendors
  • Other Prominent Vendors
  • Strategic Recommendations
  • Quantitative Summary
  • Abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/1igzsf

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • US Clinical Trial Data Management Service Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Supportive Living Services Expert Melissa Fields Shares Why Community Can Be Just as Important as Care for HelloNation

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

DeFi Crypto Mutuum Finance (MUTM) Reaches Over 18,700 Investors as V1 Protocol Launch Nears

Mutuum Finance (MUTM) Reports Ongoing Roadmap Progress With Halborn Security Audit Finalized

New Crypto Mutuum Finance (MUTM) Reports Development Progress with Over $19.7M Raised Since 2025

Stella Adler Foundation Reading of ‘All The President’s Men’ Sells Out With Cast Including: Mark Ruffalo, Ethan Hawke, Amy Brenneman, Don Cheadle, Kaley Cuoco, Laurence Fishburne, Spencer Garrett, Rob Morrow, Tom Pelphrey, Susan Traylor, Missy Yager, and More

Stella Adler Foundation Reading of ‘All The President’s Men’ Sells Out With Cast Including: Mark Ruffalo, Ethan Hawke, Amy Brenneman, Don Cheadle, Kaley Cuoco, Laurence Fishburn, Spencer Garrett, Rob Morrow, Tom Pelphrey, Susan Traylor, Missy Yager, and More

Property Value Explained by Real Estate Expert Luke Williams of Bowling Green, KY for HelloNation

Editors Picks

Supportive Living Services Expert Melissa Fields Shares Why Community Can Be Just as Important as Care for HelloNation

January 11, 2026

Kevlar in the classroom: teacher union warns of violence rise in Manitoba

January 11, 2026

Google’s AI Inbox could be a glimpse of Gmail’s future

January 11, 2026

The full history of TiVo, and how it changed TV forever

January 11, 2026

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health

January 11, 2026

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

January 11, 2026

DeFi Crypto Mutuum Finance (MUTM) Reaches Over 18,700 Investors as V1 Protocol Launch Nears

January 11, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version